glp-1 and ibd Adjunctive GLP1 Receptor Agonists in Patients With Inflammatory Bowel Diseases Obesity and/or Diabetes: A Target Trial Emulation GLP-1RAs for IBD | Docwire

Curr Treat Options Gastro 22 , 145154 (2024)

[DOI] [PMC free article] [PubMed] [Google Scholar] 36

Many online peptide therapy clinics offer bundled programs that include initial consultation, ongoing medical supervision, medication sourcing, and shipping for a single monthly fee ranging from $400 to $700

These biological products contain peptide molecules that are susceptible to degradation when exposed to temperatures outside the recommended range

Since the drug has not been tested when used this way, the potential for unwanted side effects may be higher

India has the worlds second-largest population of type-2 diabetes patients. Obesity rates are also a growing concern in India, and, as in the United States, Ozempic may be used to treat diabetes or be prescribed off-label for weight loss purposes in India